Le Van is a third-year Ph.D. student at the Laboratory of Pharmaceutics and Biopharmaceutics of the Université Libre de Bruxelles (ULB, Belgium) under the supervision of Prof. Dr. Karim Amighi and Prof. Dr. Nathalie Wauthoz.
Le Van holds a Master’s degree in Biomedical Sciences from the Université Libre de Bruxelles (ULB) and is deeply committed to advancing healthcare. Over the past several years, he has contributed to a range of research projects in public health, focusing on both infectious and genetic diseases.
Currently pursuing a Ph.D., his research centers on the development of innovative dry powder inha-lation (DPI) therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD). His work aims to enhance treatment adherence, a key factor in improving disease control and prevention. Through this project, he aspires to make a meaningful and lasting contribution to public health.
